Christopher S. Destro - Net Worth and Insider Trading
Christopher S. Destro Net Worth
The estimated net worth of Christopher S. Destro is at least $2 dollars as of 2024-11-13. Christopher S. Destro is the Sr. VP, Sales and Marketing of Atossa Therapeutics Inc and owns about 1 shares of Atossa Therapeutics Inc (ATOS) stock worth over $2. Details can be seen in Christopher S. Destro's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher S. Destro has not made any transactions after 2014-05-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher S. Destro
Christopher S. Destro Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher S. Destro owns 1 companies in total, including Atossa Therapeutics Inc (ATOS) .
Click here to see the complete history of Christopher S. Destro’s form 4 insider trades.
Insider Ownership Summary of Christopher S. Destro
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATOS | Atossa Therapeutics Inc | 2015-03-16 | SVP & Sales and Marketing |
Christopher S. Destro Latest Holdings Summary
Christopher S. Destro currently owns a total of 1 stock. Christopher S. Destro owns 1 shares of Atossa Therapeutics Inc (ATOS) as of May 6, 2014, with a value of $2.
Latest Holdings of Christopher S. Destro
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATOS | Atossa Therapeutics Inc | 2014-05-06 | 1 | 1.50 | 2 |
Holding Weightings of Christopher S. Destro
Christopher S. Destro Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher S. Destro has made a total of 0 transactions in Atossa Therapeutics Inc (ATOS) over the past 5 years. The most-recent trade in Atossa Therapeutics Inc is the sale of 0 shares on May 6, 2014, which brought Christopher S. Destro around $0.
Insider Trading History of Christopher S. Destro
- 1
Christopher S. Destro Trading Performance
Christopher S. Destro Ownership Network
Ownership Network List of Christopher S. Destro
Ownership Network Relation of Christopher S. Destro
Christopher S. Destro Owned Company Details
What does Atossa Therapeutics Inc do?
Who are the key executives at Atossa Therapeutics Inc?
Christopher S. Destro is the SVP & Sales and Marketing of Atossa Therapeutics Inc. Other key executives at Atossa Therapeutics Inc include SVP & Finance and Accounting Heather Rees , CFO & General Counsel Kyle Guse , and director & 10 percent owner & Chief Scientific Officer Shu-chih Chen .
Atossa Therapeutics Inc (ATOS) Insider Trades Summary
Over the past 18 months, Christopher S. Destro made no insider transaction in Atossa Therapeutics Inc (ATOS). Other recent insider transactions involving Atossa Therapeutics Inc (ATOS) include a net sale of 0 shares made by Gregory L Weaver , and a net purchase of 25,000 shares made by Jonathan Finn .
In summary, during the past 3 months, insiders sold 0 shares of Atossa Therapeutics Inc (ATOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 50,000 shares of Atossa Therapeutics Inc (ATOS) were sold and 75,000 shares were bought by its insiders, resulting in a net purchase of 25,000 shares.
Atossa Therapeutics Inc (ATOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Atossa Therapeutics Inc Insider Transactions
Christopher S. Destro Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher S. Destro. You might contact Christopher S. Destro via mailing address: C/o Atossa Genetics Inc., 1616 Eastlake Ave. East, Suite 510, Seattle Wa 98102.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
